|
18 Dec 2019 |
Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody
|
|
18 Dec 2019 |
Cerevance Enters Research Collaboration with Takeda to Advance New Treatments for Gastrointestinal Disorders
|
|
11 Dec 2019 |
GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery
|
|
10 Dec 2019 |
AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics
|
|
09 Dec 2019 |
Samyang Biopharm USA, Inc. and Talix Therapeutics NV Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
|
|
09 Dec 2019 |
Merck to Acquire ArQule, Advancing Leadership in Oncology
|
|
09 Dec 2019 |
Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
|
|
09 Dec 2019 |
Healx Joins Forces with Boehringer Ingelheim to Discover New Treatment Approaches for Rare Neurological Diseases
|
|
08 Dec 2019 |
Denovo Biopharma Licenses Global Rights to a Novel Late-Stage Oncology Drug from Sunesis Pharmaceuticals
|
|
08 Dec 2019 |
Janssen to Acquire Investigational Bermekimab from XBiotech
|
|
06 Dec 2019 |
Cerecor to Acquire Aevi Genomic Medicine
|
|
04 Dec 2019 |
Gatehouse Bio collaborates with AstraZeneca to accelerate new drug discovery
|
|
03 Dec 2019 |
Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics
|
|
02 Dec 2019 |
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
|
|
02 Dec 2019 |
Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
|
|
27 Nov 2019 |
Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy
|
|
26 Nov 2019 |
Woolsey Pharmaceuticals Signs License Agreement With Asahi Kasei Pharma for Exclusive Rights to Fasudil
|
|
25 Nov 2019 |
Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis
|
|
25 Nov 2019 |
Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
|
|
21 Nov 2019 |
Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer
|
|
21 Nov 2019 |
ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention
|
|
21 Nov 2019 |
Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration
|
|
21 Nov 2019 |
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
|
|
20 Nov 2019 |
Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications
|
|
20 Nov 2019 |
Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology
|
